Part of Phaidon International
Part of Phaidon International
Showing 20 results
Sort by:
About the OpportunityAn innovative clinical-stage biotechnology company is seeking an experienced Clinical Trial Manager to support the delivery of next-generation therapies and vaccines. This is an opportunity to join a highly collaborative, science-driven environment focused on advancing novel treatment approaches and improving patient outcomes w...
The OpportunityThis is a rare chance to step in as the in‑region clinical operations lead for APAC at a privately backed, clinical‑stage biotech entering a decisive phase of growth. The company has moved beyond platform promise into execution - multiple programs advancing, real patients enrolling, and global timelines that now depend on strong regi...
The OpportunityThis is a rare chance to step in as the in‑region clinical operations lead for APAC at a privately backed, clinical‑stage biotech entering a decisive phase of growth. The company has moved beyond platform promise into execution - multiple programs advancing, real patients enrolling, and global timelines that now depend on strong regi...
Take the first step toward your next opportunity - submit your CV and get started today.
Senior Clinical Trial Manager | Waltham, MA$150k-$185kOur client is a well-funded, publicly traded clinical-stage biotechnology company developing next-generation biologics for chronic inflammatory diseases. With multiple late-stage clinical programs and substantial capital to support growth, the organization is entering an exciting phase of expans...
Senior Clinical Trial Manager | Waltham, MA$150k-$185kOur client is a well-funded, publicly traded clinical-stage biotechnology company developing next-generation biologics for chronic inflammatory diseases. With multiple late-stage clinical programs and substantial capital to support growth, the organization is entering an exciting phase of expans...
Senior Clinical Trial Manager | Waltham, MA$150k-$185kOur client is a well-funded, publicly traded clinical-stage biotechnology company developing next-generation biologics for chronic inflammatory diseases. With multiple late-stage clinical programs and substantial capital to support growth, the organization is entering an exciting phase of expans...